Open AccessStroke Biomarkers: Progress and Challenges for Diagnosis, Prognosis, Differentiation, and Treatment
Author(s) -
Amy K. Saenger,
Robert H. Christenson
Publication year - 2009
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2009.133801
Subject(s) - medicine , stroke (engine) , intensive care medicine , biomarker , neuroimaging , thrombosis , acute stroke , point of care testing , biomarker discovery , bioinformatics , pathology , proteomics , tissue plasminogen activator , biochemistry , biology , psychiatry , gene , chemistry , engineering , mechanical engineering
Stroke is a devastating condition encompassing a wide range of pathophysiological entities that include thrombosis, hemorrhage, and embolism. Current diagnosis of stroke relies on physician clinical examination and is further supplemented with various neuroimaging techniques. A single set or multiple sets of blood biomarkers that could be used in an acute setting to diagnosis stroke, differentiate between stroke types, or even predict an initial/reoccurring stroke would be extremely valuable.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom